212 related articles for article (PubMed ID: 32212919)
21. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
Macchia E; Gasperi M; Lombardi M; Morselli L; Pinchera A; Acerbi G; Rossi G; Martino E
J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
[TBL] [Abstract][Full Text] [Related]
22. Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report.
Yang J; Liu S; Yang Z; Shi YB
Medicine (Baltimore); 2017 Dec; 96(50):e8912. PubMed ID: 29390279
[TBL] [Abstract][Full Text] [Related]
23. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
[TBL] [Abstract][Full Text] [Related]
24. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study.
Mo C; Chen H; Xu J; Guo Y; Wang Y; Li Z; Tong T; Gui S; Zhong L
Endocr Pract; 2024 May; 30(5):441-449. PubMed ID: 38307455
[TBL] [Abstract][Full Text] [Related]
25. Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins.
Gatto F; Barbieri F; Gatti M; Wurth R; Schulz S; Ravetti JL; Zona G; Culler MD; Saveanu A; Giusti M; Minuto F; Hofland LJ; Ferone D; Florio T
Clin Endocrinol (Oxf); 2012 Mar; 76(3):407-14. PubMed ID: 21848909
[TBL] [Abstract][Full Text] [Related]
26. Thyroid storm induced by TSH-secreting pituitary adenoma: a case report.
Fujio S; Ashari ; Habu M; Yamahata H; Moinuddin FM; Bohara M; Arimura H; Nishijima Y; Arita K
Endocr J; 2014; 61(11):1131-6. PubMed ID: 25132171
[TBL] [Abstract][Full Text] [Related]
27. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.
Gancel A; Vuillermet P; Legrand A; Catus F; Thomas F; Kuhn JM
Clin Endocrinol (Oxf); 1994 Mar; 40(3):421-8. PubMed ID: 8187308
[TBL] [Abstract][Full Text] [Related]
28. Management of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literature.
Ünlütürk U; Sriphrapradang C; Erdoğan MF; Emral R; Güldiken S; Refetoff S; Güllü S
J Clin Endocrinol Metab; 2013 Jun; 98(6):2210-7. PubMed ID: 23553855
[TBL] [Abstract][Full Text] [Related]
29. Thyrotropin-secreting pituitary adenomas.
Beck-Peccoz P; Persani L; Mantovani S; Cortelazzi D; Asteria C
Metabolism; 1996 Aug; 45(8 Suppl 1):75-9. PubMed ID: 8769389
[TBL] [Abstract][Full Text] [Related]
30. [Manifestations and prognosis of thyrotropin-secreting pituitary adenomas: a case series of three patients].
Latrech H; Rousseau A; Le Marois E; Billaud L; Bertagna X; Azzoug S; Raffin-Sanson ML
Rev Med Interne; 2010 Dec; 31(12):858-62. PubMed ID: 21074296
[TBL] [Abstract][Full Text] [Related]
31. [Thyrotropin-secreting pituitary adenomas].
Caron P
Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
[TBL] [Abstract][Full Text] [Related]
32. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
[TBL] [Abstract][Full Text] [Related]
33. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.
Wynne AG; Gharib H; Scheithauer BW; Davis DH; Freeman SL; Horvath E
Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235
[TBL] [Abstract][Full Text] [Related]
34. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma.
Safer JD; Colan SD; Fraser LM; Wondisford FE
Thyroid; 2001 Mar; 11(3):281-91. PubMed ID: 11327621
[TBL] [Abstract][Full Text] [Related]
35. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
Losa M; Fortunato M; Molteni L; Peretti E; Mortini P
Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
[TBL] [Abstract][Full Text] [Related]
36. Case Report and Literature Review: Ectopic Thyrotropin-Secreting Pituitary Adenoma in the Suprasellar Region.
Li X; Zhao B; Hou B; Wang J; Zhu J; Yao Y; Lian X
Front Endocrinol (Lausanne); 2021; 12():619161. PubMed ID: 33776916
[TBL] [Abstract][Full Text] [Related]
37. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
[TBL] [Abstract][Full Text] [Related]
38. In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5.
Gatto F; Barbieri F; Castelletti L; Arvigo M; Pattarozzi A; Annunziata F; Saveanu A; Minuto F; Castellan L; Zona G; Florio T; Ferone D
Pituitary; 2011 Jun; 14(2):141-7. PubMed ID: 21086053
[TBL] [Abstract][Full Text] [Related]
39. Medical management of thyrotropin-secreting pituitary adenomas.
Beck-Peccoz P; Persani L
Pituitary; 2002; 5(2):83-8. PubMed ID: 12675505
[TBL] [Abstract][Full Text] [Related]
40. Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review.
Yang C; Wu H; Wang J; Hu M; Xing X; Bao X; Wang R
Medicine (Baltimore); 2017 Sep; 96(36):e8017. PubMed ID: 28885368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
